HESTERBIONSEHester Biosciences LimitedMediumNeutral
Announced Fri, 15 May · 12:26 IST

Hester Biosciences Limited has informed the Exchange about Intimation of receipt of request for Reclassification from the Promoters to the Public category in accordance with Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Ownership Changes View source PDF

HESTERBIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.6%1-day move
₹1749.00
prior close
₹1955.50
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.5+0.2+0.2-0.4+1.6+3.8+5.2+7.8+8.2+21.8+11.7+18.8+37.4
Up moveDown movePending
AI summary

Hester Biosciences has received requests from two promoters seeking reclassification to the Public category. Mr. Ravin Gandhi (4.74% stake, 403,320 shares) and Ms. Bela Gandhi (4.71% stake, 400,635 shares) together hold approximately 9.45% of the company. Both individuals have confirmed they have no board positions, managerial roles, or control over the company, and their holdings are passive investments. Ravin Gandhi resigned from the Board on May 12, 2026. Bela Gandhi states she has not been involved in management for over 12 years. The company will now process these requests per SEBI regulations, requiring shareholder approval before final reclassification.

Likely market impact

If approved, the combined 9.45% stake held by these two individuals will shift from promoter holding to public holding, potentially affecting the company's promoter group ownership calculations. This is a routine regulatory process and does not indicate any change in business operations or share sales.